Tempus AI News - July 20, 2026
Tempus AI Announces Agreement to Acquire Personalis, Inc. for $16.25 Per Share
Tempus AI, Inc. (TEM) has entered into a definitive merger agreement to acquire Personalis, Inc. in a stock and potential cash transaction. The deal values...
Tempus AI to Acquire Personalis for $1.5 Billion to Expand Cancer Monitoring
Tempus AI (TEM) announced it has entered into a definitive agreement to acquire Personalis, Inc. (PSNL) for a total enterprise value of $1.5 billion. The...
Tempus AI to acquire Personalis for $1.5B, expanding cancer monitoring tech
Tempus AI (NASDAQ: TEM) signed a definitive agreement to acquire Personalis, Inc. (NASDAQ: PSNL) for approximately $1.5 billion. The deal values Personalis at...
🔴 Tempus AI is trading 6.1% down today on muted 2026 guidance and sector rotation
Tempus AI is trading at $49.26 (6.1% down) amid continued weakness in high-growth AI and healthcare technology stocks. • The decline extends a multi-session...
🔴 Tempus AI is trading 5.4% down today as AI rotation continues
Tempus AI is trading 5.4% down at $49.65 amid ongoing weakness in high-growth AI and healthcare technology names. • The stock has been sliding for several...